145 related articles for article (PubMed ID: 23097091)
21. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation and gene silencing in cancer: which is the guilty party?
Clark SJ; Melki J
Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
[TBL] [Abstract][Full Text] [Related]
23. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
[TBL] [Abstract][Full Text] [Related]
25. Gene body-specific methylation on the active X chromosome.
Hellman A; Chess A
Science; 2007 Feb; 315(5815):1141-3. PubMed ID: 17322062
[TBL] [Abstract][Full Text] [Related]
26. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
28. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
29. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
30. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
31. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
32. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
Xu X; Tan X; Tampe B; Nyamsuren G; Liu X; Maier LS; Sossalla S; Kalluri R; Zeisberg M; Hasenfuss G; Zeisberg EM
Cardiovasc Res; 2015 Mar; 105(3):279-91. PubMed ID: 25616414
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC; To SQ; Simpson ER; Clyne CD
Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
[TBL] [Abstract][Full Text] [Related]
36. Methylation determines fibroblast activation and fibrogenesis in the kidney.
Bechtel W; McGoohan S; Zeisberg EM; Müller GA; Kalbacher H; Salant DJ; Müller CA; Kalluri R; Zeisberg M
Nat Med; 2010 May; 16(5):544-50. PubMed ID: 20418885
[TBL] [Abstract][Full Text] [Related]
37. Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis.
Tampe B; Tampe D; Müller CA; Sugimoto H; LeBleu V; Xu X; Müller GA; Zeisberg EM; Kalluri R; Zeisberg M
J Am Soc Nephrol; 2014 May; 25(5):905-12. PubMed ID: 24480825
[TBL] [Abstract][Full Text] [Related]
38. The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Sep; 25(9):1870-6. PubMed ID: 23707521
[TBL] [Abstract][Full Text] [Related]
39. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.
Sanders YY; Pardo A; Selman M; Nuovo GJ; Tollefsbol TO; Siegal GP; Hagood JS
Am J Respir Cell Mol Biol; 2008 Nov; 39(5):610-8. PubMed ID: 18556592
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Garate L; Jose-Eneriz ES; Cordeu L; Barrios M; Prosper F; Heiniger A; Torres A
Leukemia; 2006 Aug; 20(8):1445-8. PubMed ID: 16688225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
